Search Result "KRN951"
Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 18-31
Author(s): D. Xu, T.-L. Wang, L.-P. Sun, Q.-D. You
Vascular Endothelial Growth Factor Receptors [VEGFR] as Target inBreast Cancer Treatment: Current Status in Preclinical and ClinicalStudies and Future Directions
Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 11 Year: 2022 Page: 891-920
Author(s): Mohammad Ali Ebrahimzadeh
Recent Advances in Antiangiogenic Agents with VEGFR as Target
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 920-946
Author(s): J. Zhang, Y. Shan, X. Pan, L. He
Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 1 Year: 2008 Page: 1058-1077
Author(s): Snezana K. Bjelogrlic, Sinisa Radulovic, Nada Babovic
VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 5 Year: 2011 Page: 624-653
Author(s): P. S. Sharma, R. Sharma, T. Tyagi
Tyrosine Kinases as Targets for Anti-Inflammatory Therapy
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2007 Page: 47-60
Author(s): Teruko Tamura, Alexandra Koch
Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 1065-1075
Author(s): R. Nahta
Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1571-1590
Author(s): Haizhen Zhong, J. Phillip Bowen
Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 31-49
Author(s): Ugo Testa